BRIGHT-4 trial: bivalirudin strikes back - Authors' reply
- PMID: 37030890
- DOI: 10.1016/S0140-6736(23)00270-2
BRIGHT-4 trial: bivalirudin strikes back - Authors' reply
Comment on
-
BRIGHT-4 trial: bivalirudin strikes back.Lancet. 2023 Apr 8;401(10383):1157-1158. doi: 10.1016/S0140-6736(23)00280-5. Lancet. 2023. PMID: 37030888 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
